Responsiveness of the Spanish Version of the “Skin Cancer Index”

Background. Skin Cancer Index (SCI) is a specific questionnaire measuring health related quality of life (HRQL) in patients with cervicofacial non-melanoma skin cancer (CFNMSC). The original scale has recently been adapted and validated into Spanish. Objectives. Evaluate the responsiveness of the Spanish version of SCI. Methods. Patients with CFNMSC candidate for surgical treatment were administered the questionnaire at time of diagnostic (t 0), 7 days after surgery (t 1), and 5 months after surgery (t 2). The scale and subscales scores (C1: social/appearance, C2: emotional) were then evaluated. Differences between t 0-t 1, t 1-t 2, and t 0-t 2 were determined and a gender-and-age segmented analysis was performed. Results. 88 patients, 54.8% male, mean age 62.5 years, completed the study. Differences between t 0-t 1 and t 1-t 2 scores were statistically significant (p < 0.05). The lowest values were found at time of diagnosis and postsurgery. Women and patients under 65 years showed the lowest values at the three times. Limitations. Concrete geographic and cultural area. Clinical and histological variables are not analysed. Conclusions. Our results confirm responsiveness of the Spanish version of the SCI. Further development of the instrument in Spanish-speaking countries and populations will make it possible to extend worldwide research and knowledge horizons on skin cancer.

[1]  R. Sarpong,et al.  Bio-inspired synthesis of xishacorenes A, B, and C, and a new congener from fuscol† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c9sc02572c , 2019, Chemical science.

[2]  M. Aguilar-Bernier,et al.  A Spanish version of the skin cancer index: a questionnaire for measuring quality of life in patients with cervicofacial nonmelanoma skin cancer , 2015, The British journal of dermatology.

[3]  L. Ferreira,et al.  Quality of life and self-esteem in patients submitted to surgical treatment of skin carcinomas: long-term results* , 2014, Anais brasileiros de dermatologia.

[4]  A. Körner,et al.  Nonmelanoma skin cancer: disease-specific quality-of-life concerns and distress. , 2014, Oncology nursing forum.

[5]  J. Coebergh,et al.  Trends in Basal cell carcinoma incidence rates: a 37-year Dutch observational study. , 2013, The Journal of investigative dermatology.

[6]  José María Ramada-Rodilla,et al.  Adaptación cultural y validación de cuestionarios de salud: revisión y recomendaciones metodológicas , 2013 .

[7]  José María Ramada-Rodilla,et al.  [Cross-cultural adaptation and health questionnaires validation: revision and methodological recommendations]. , 2013, Salud publica de Mexico.

[8]  C. Di Pietro,et al.  Field performance of the Skindex-17 quality of life questionnaire: a comparison with the Skindex-29 in a large sample of dermatological outpatients. , 2013, The Journal of investigative dermatology.

[9]  A. Körner,et al.  Distress and Coping Strategies Among Patients with Skin Cancer , 2013, Journal of Clinical Psychology in Medical Settings.

[10]  Cemal Cingi,et al.  Epidemiology and economic burden of nonmelanoma skin cancer. , 2012, Facial plastic surgery clinics of North America.

[11]  G. Spyrou,et al.  The psycho-social impact of facial skin cancers. , 2012, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.

[12]  J. Leonardi-Bee,et al.  A systematic review of worldwide incidence of nonmelanoma skin cancer , 2012, The British journal of dermatology.

[13]  M. Chren The Skindex instruments to measure the effects of skin disease on quality of life. , 2012, Dermatologic clinics.

[14]  Miguel Ángel Martínez,et al.  Cómo validar un instrumento de medida de la salud , 2011 .

[15]  M. Landthaler,et al.  Quality of life in health care of non‐melanoma skin cancer – results of a pilot study , 2011, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[16]  C. Centeno,et al.  [How is an instrument for measuring health to be validated?]. , 2011, Anales del sistema sanitario de Navarra.

[17]  H. F. van Tuijl,et al.  Need for a new skin cancer management strategy. , 2010, Archives of dermatology.

[18]  J. Lear,et al.  Non-melanoma skin cancer , 2010, The Lancet.

[19]  S. Arias-Santiago,et al.  Evolución de la incidencia del cáncer de piel en el período 1978–2002 , 2010 .

[20]  David A. Lee,et al.  Nonmelanoma skin cancer. , 2009, Facial plastic surgery clinics of North America.

[21]  M. Chren,et al.  Predictors of skin-related quality of life after treatment of cutaneous basal cell carcinoma and squamous cell carcinoma. , 2007, Archives of dermatology.

[22]  M. Chren,et al.  Quality-of-life outcomes of treatments for cutaneous basal cell carcinoma and squamous cell carcinoma. , 2007, The Journal of investigative dermatology.

[23]  B. Logan,et al.  The Skin Cancer Index: Clinical Responsiveness and Predictors of Quality of Life , 2007, The Laryngoscope.

[24]  M. Lotem,et al.  Ultraviolet radiation and cutaneous carcinogenesis. , 2007, Current problems in dermatology.

[25]  B. Logan,et al.  Validation of a quality-of-life instrument for patients with nonmelanoma skin cancer. , 2006, Archives of facial plastic surgery.

[26]  M. Neuburg,et al.  Development of the Facial Skin Care Index: A Health‐Related Outcomes Index for Skin Cancer Patients , 2006, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[27]  G. Murphy,et al.  The impact of skin disease following renal transplantation on quality of life , 2005, The British journal of dermatology.

[28]  M. Neuburg,et al.  Creation of a Quality of Life Instrument for Nonmelanoma Skin Cancer Patients , 2005, The Laryngoscope.

[29]  Timothy L. Smith,et al.  Skin Cancer and Quality of Life: Assessment With the Dermatology Life Quality Index , 2004, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[30]  Timothy L. Smith,et al.  Quality of life and sun-protective behavior in patients with skin cancer. , 2004, Archives of otolaryngology--head & neck surgery.

[31]  A. Finlay,et al.  Basal cell carcinomas cause little handicap , 1996, Quality of Life Research.

[32]  Timothy L. Smith,et al.  Quality of Life Assessment in Nonmelanoma Cervicofacial Skin Cancer , 2003, The Laryngoscope.

[33]  J. Spencer,et al.  Basal and squamous cancer of the facial skin , 1997 .

[34]  S. Frankel,et al.  Non-melanoma Skin Cancer , 2021, Surgical Oncology Manual.

[35]  J. M. C. Hita La medida de la salud , 1981 .